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Identifying the small number of rare causal variants contributing to disease has
been a major focus of investigation in recent years, but represents a formidable
statistical challenge due to the rare frequencies with which these variants are observed.
In this commentary we draw attention to a formal statistical framework, namely
hierarchical modeling, to combine functional genomic annotations with sequencing
data with the objective of enhancing our ability to identify rare causal variants. Using
simulations we show that in all configurations studied, the hierarchical modeling
approach has superior discriminatory ability compared to a recently proposed aggregate
measure of deleteriousness, the Combined Annotation-Dependent Depletion (CADD)
score, supporting our premise that aggregate functional genomic measures can more
accurately identify causal variants when used in conjunction with sequencing data
through a hierarchical modeling approach.
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Identifying a small number of variants most likely to be causal in a specific genetic region (such as a
gene) is a challenging problem, but of fundamental importance to the understanding of precise
biological mechanisms that influence disease (MacArthur et al., 2014). Rare causal variants, by
definition, are only seen a small number of times in any given dataset and therefore are hard to
distinguish from the abundant natural variation that occurs in any particular gene. This is a difficult
setting, where the causal variants are sparse and tend to be weak as well. Experimental functional
studies are the gold-standard, but they are expensive and difficult to implement for large number of
variants. Statistical methods to help us distinguish between a true causal variant and a null variant
are therefore of great interest.
For those causal variants that are rare but appear at sufficient frequency in a dataset, it is
possible to prioritize them over other variants in a gene using genetic (i.e., frequency) data alone.
However, for those causal variants that are observed only a few times (e.g., singletons, doubletons
etc.), clearly these frequencies on their own are insufficient to provide meaningful risk predictions
and no method will perform better than random guessing based on genetic data alone. It is for
these variants that functional genomic annotations are essential. Large-scale studies such as the
Encyclopedia of DNA Elements (ENCODE) project (ENCODE Project Consortium et al., 2012)
provide rich functional genomics annotations that can complement genetic data and help identify
likely causal variants. Aggregate measures (Frousios et al., 2013; Johansen et al., 2013; Kircher et al.,
2014; Ritchie et al., 2014) that combine information across many annotations in a single measure of
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deleteriousness for a variant have been shown to outperform
individual annotations. The usefulness of such functional
measures depends on how well they correlate with pathogenicity.
Clearly this correlation will depend on the disease or trait under
study and possibly the gene or region of interest (e.g., the degree
to which a gene is intolerant to functional variation Petrovski
et al., 2013).
It seems natural to expect that combining these two pieces
of evidence: (1) the genetic score measuring the statistical
evidence for a variant being associated with a disease of interest,
and (2) various functional scores for the variant, can enhance
the ability to identify rare causal variants. In Supplementary
Figure 1 we show three possible outcomes for correctly classifying
a true causal variant as likely causal as a function of both
genetic and functional scores. Evidently, causal variants with
low functional scores and low support from genetic data (e.g.,
singletons or doubletons) will be impossible to classify correctly.
At the other extreme, the causal variants with strong support
from both genetic and functional scores will be easy to identify.
For causal variants falling in-between these two extremes for
which neither the genetic data nor the functional scores on
their own provide sufficient evidence of their deleteriousness we
believe that integrative methods that combine genetic data with
functional scores would be most useful for correctly identifying
these variants. Indeed, a recent report by a working group of
researchers convened by the NHGRI discussed the challenges
in reliably implicating sequence variants in human disease,
and highlighted the importance of performing “a combined
assessment of the genetic, experimental and informatic support
for individual candidate variants” (MacArthur et al., 2014).
Hierarchical models (Gelman et al., 2003) provide a natural
approach for such an integrative analysis. They offer a formal
statistical framework that can be used in this setting to
incorporate sequencing data and functional annotations with
the goal of identifying rare causal variants. The strength of the
hierarchical modeling approach comes from the fact that it draws
upon the information contained in functional annotations to
augment the weak information from the case/control frequencies
for rare variants, thus improving the risk estimation for
individual variants. In our setting, the hierarchical model has
two levels: the first level contains the parameters of fundamental
interest, namely the relative risks conferred by the individual
genetic variants, and also individual-level confounding factors.
In the second level, the individual log relative risks of the variants
are modeled as linear functions of relevant functional scores.
More details on the hierarchical modeling approach and its
properties as well as applications to two large population-based
case-control studies of melanoma and breast cancer can be found
in Capanu et al. (2008), Capanu and Begg (2011), Capanu et al.
(2011). A recent application of hierarchical modeling to VPS13B,
a gene involved in Cohen syndrome and autism can be found in
Ionita-Laza et al. (2014).
We conjecture that a hierarchical modeling approach
incorporating the sequencing data with an aggregate functional
measure more accurately classifies rare causal variants compared
to a ranking based solely on the variants’ functional score. We
focus here on the recently proposed deleteriousness measure,
the Combined Annotation-Dependent Depletion (CADD) score
or C-score (Kircher et al., 2014), but our method can include
any such genomic annotations.We investigate the discriminatory
ability of this hierarchical modeling approach and that of the
ranking based on the C-scores alone using simulations based on
exome sequencing data for 861 individuals (part of the ARRA
Autism Sequencing Collaborative project) for one gene, VPS13B,
containing 166 observed single nucleotide variants (SNVs). We
assumed 10% of SNVs to be truly causal variants, with relative
risks of 1.1, 2, or 4 for the association of the C-score and
the causal status of a variant. We then generated the case-
control status following the same data generating mechanism
as in Ladouceur et al. (2012). Specifically, for carriers of causal
variants we generated a continuous phenotype from a normal
distribution with mean µ = 0.5 and a standard deviation of 0.2
while for non-carriers we used a standard normal distribution.
This corresponds to a moderate standardized effect size of 0.5
(Cohen, 1988). Note that smaller standardized effect sizes were
also examined and the results were qualitatively the same (data
not shown). Furthermore, individuals with phenotype values
above the median were classified as cases, and the remaining
individuals as controls.
The ROC curves for the two different methods are displayed
in Figure 1 under different degrees of associations between
the causal status and the C-scores and assuming µ = 0.5.
Solid curves correspond to ROC curves based on the z-values
estimated from a hierarchical model in which the C-scores were
FIGURE 1 | ROC curves of the z-values estimated from a hierarchical
model with the C-scores included as a functional predictor (solid
curves) and ROC curves based on the ranking of the C-scores of
variants carried in at least one of the cases (dashed curves); 10% of
variants are assumed truly causal variants; associations between the
C-score and the causal status of a variant vary from relative risks of
1.1 (blue), to 2 (green), and 4 (red); µ, the effect size as a function of
standard deviations, is assumed to be 0.5; estimates are averaged
across 400 simulations.
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the solely functional predictor, while dashed curves correspond
to rankings based on the C-scores of variants that occurred in
at least one of the cases. In all configurations, the hierarchical
modeling approach has superior discriminatory ability to the
C-score method, with biggest improvements observed when
the functional score is weakly associated with the causal
status (RR = 1.1, blue curves). As the association of the C-
scores with the causal status gets stronger, the discriminatory
ability of the two methods also improves. Similar trends are
observed for larger values of µ such as 1, 1.5, and 2 (data not
shown).
In conclusion, aggregate functional measures such as the C-
score can identify causal variants more accurately when used
in conjunction with sequencing data through a hierarchical
modeling approach than when used on their own. Therefore,
hierarchical models and other integrative methods are promising
tools in this context, and further work in developing such
methods is warranted to take full advantage of rich functional
annotation data and large scale sequencing studies for many
complex diseases in order to understand the nature of the causal
variants involved in these diseases.
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